Teladoc Health Sees Unusually Large Options Volume (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) was the target of some unusual options trading on Tuesday. Stock investors bought 22,980 call options on the company. This represents an increase of 69% compared to the typical volume of 13,593 call options.

Insider Activity at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.95% of the stock is currently owned by corporate insiders.

Institutional Trading of Teladoc Health

Institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp increased its position in Teladoc Health by 1.7% during the second quarter. Bank of New York Mellon Corp now owns 916,129 shares of the health services provider’s stock worth $8,960,000 after acquiring an additional 14,910 shares during the period. Principal Financial Group Inc. increased its holdings in shares of Teladoc Health by 27.8% during the second quarter. Principal Financial Group Inc. now owns 17,674 shares of the health services provider’s stock worth $173,000 after purchasing an additional 3,841 shares during the period. Rhumbline Advisers boosted its stake in shares of Teladoc Health by 62.9% in the second quarter. Rhumbline Advisers now owns 276,535 shares of the health services provider’s stock valued at $2,704,000 after buying an additional 106,770 shares during the period. Arizona State Retirement System raised its holdings in Teladoc Health by 4.2% in the 2nd quarter. Arizona State Retirement System now owns 47,400 shares of the health services provider’s stock valued at $464,000 after acquiring an additional 1,901 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its position in shares of Teladoc Health by 391.4% during the 2nd quarter. Acadian Asset Management LLC now owns 32,607 shares of the health services provider’s stock valued at $318,000 after acquiring an additional 25,971 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Barclays lifted their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Evercore ISI upped their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a report on Friday, November 15th. They set a “buy” rating and a $14.00 price objective on the stock. Royal Bank of Canada boosted their target price on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health has an average rating of “Hold” and an average target price of $12.24.

View Our Latest Analysis on TDOC

Teladoc Health Stock Up 0.3 %

Shares of NYSE TDOC traded up $0.03 during trading hours on Tuesday, hitting $9.96. The company had a trading volume of 2,357,082 shares, compared to its average volume of 3,151,970. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $22.16. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm’s 50 day moving average is $9.90 and its 200-day moving average is $9.03. The stock has a market capitalization of $1.71 billion, a P/E ratio of -1.73 and a beta of 1.01.

Teladoc Health (NYSE:TDOCGet Free Report) last issued its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. On average, analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Recommended Stories

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.